02/20/2025
4:23 PM | Anebulo Pharmaceuticals (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
02/14/2025
3:30 PM | Anebulo Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
02/14/2025
3:15 PM | Anebulo Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/12/2025
6:00 AM | Anebulo Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/30/2024
5:38 PM | Anebulo Pharmaceuticals (Filer)
| Form D
Notice of Exempt Offering of Securities | |
12/26/2024
8:42 PM | Anebulo Pharmaceuticals (Subject)
English Aron R. (Filed by)
| Form SCHEDULE 13D/A | |
12/26/2024
3:15 PM | 22NW Fund, LP (Reporting)
Anebulo Pharmaceuticals (Issuer)
English Aron R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/23/2024
3:56 PM | Anebulo Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/10/2024
8:00 AM | Anebulo Pharmaceuticals (Issuer)
Cunningham, Richard Anthony (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/13/2024
3:30 PM | Anebulo Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/13/2024
3:15 PM | Anebulo Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/17/2024
6:00 AM | Anebulo Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/25/2024
3:30 PM | Anebulo Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
09/25/2024
3:15 PM | Anebulo Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/22/2024
6:05 AM | Anebulo Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/17/2024
3:23 PM | Anebulo Pharmaceuticals (Issuer)
Aryeh Jason (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
3:23 PM | Anebulo Pharmaceuticals (Issuer)
SHAH BIMAL R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
3:23 PM | Anebulo Pharmaceuticals (Issuer)
English Aron R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
3:23 PM | Anebulo Pharmaceuticals (Issuer)
Lawler Joseph F. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
3:23 PM | Anebulo Pharmaceuticals (Issuer)
Kupchyk Areta (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
3:23 PM | Anebulo Pharmaceuticals (Issuer)
Calloway Nathaniel (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
3:23 PM | Anebulo Pharmaceuticals (Issuer)
Lin Kenneth (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
7:07 AM | Anebulo Pharmaceuticals (Issuer)
Cundy Kenneth C (Reporting)
| Form 4/A | |
03/01/2024
5:24 PM | Anebulo Pharmaceuticals (Issuer)
Cundy Kenneth C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Free ANEB Stock Alerts